Cancer Burden and Trend
Disease burden of kidney cancer, bladder cancer and prostate cancer in population in China, 1990-2019
Wang Le, Li Huizhang, Zhu Juan, Wang Zongping, Du Lingbin
Published 2024-05-10
Cite as Chin J Epidemiol, 2024, 45(5): 640-646. DOI: 10.3760/cma.j.cn112338-20231102-00268
Abstract
ObjectiveTo analyze the disease burden of kidney cancer, bladder cancer and prostate cancer and attributed risk factors in China from 1990 to 2019, and provide reference for the development of comprehensive prevention and control strategies.
MethodsBased on the Global Burden of Disease Study 2019 platform, we collected the crude and age-standardized incidence rate, age-standardized mortality rate (ASMR), and disability-adjusted life year (DALY) of kidney cancer, bladder cancer and prostate cancer in China from 1990 to 2019. By using the log-linear regression model, trends were analyzed for overall and risk-attributable disease burden by calculating the average annual percentage change (AAPC).
ResultsFrom 1990 to 2019, the crude incidence rates of kidney cancer, bladder cancer and prostate cancer showed increasing trends in China, with an AAPC of 5.4% (95%CI: 4.9% - 5.9%), 4.1% (95%CI: 3.9% - 4.2%) and 5.6% (95%CI: 5.3% - 6.0%) (all P<0.001), respectively. Similar trends were found in age-standardized incidence rates with smaller AAPCs. For kidney cancer, the ASMR and age-standardized DALY rate significantly increased, with AAPC of 2.2% (95%CI: 1.5%-2.8%) and 1.5% (95%CI: 1.2%-1.9%) (all P<0.001), while the ASMR of bladder cancer and prostate cancer decreased gradually, with AAPC of -0.6% (95%CI: -0.7% - -0.5%) (P<0.001) and -0.2% (95%CI: -0.3% - -0.1%) (P=0.002). The age-standardized DALY rate of bladder cancer and prostate cancer decreased gradually, with AAPC of -0.6% (95%CI: -0.8% - -0.4%) (P<0.001) and -0.2% (95%CI: -0.3% - -0.1%) (P=0.002). Smoking was responsible for 48.2% of bladder cancer, 18.8% of kidney cancer and 9.8% of prostate cancer in total DALY. The age-standardized DALY rate of kidney cancer caused by smoking and high BMI showed an increasing trend, with AAPC of 3.0% (95%CI: 2.8%-3.2%) and 4.9% (95%CI: 4.7%-5.0%) (all P<0.001), and smoking-attributed age-standardized DALY rates of bladder cancer and prostate cancer decreased gradually with AAPC of -0.4% (95%CI: -0.6% - -0.2%) (P<0.001) and -0.3% (95%CI: -0.4% - -0.1%) (P=0.001).
ConclusionsIn the past 30 years, the disease burden of kidney cancer, bladder cancer and prostate cancer in China increased gradually, while the deaths and DALY of bladder cancer and prostate cancer decreased slightly. We should continue to strengthen the primary prevention strategies for smoking, obesity and other risk factors, and explore the appropriate screening tests and population-based screening strategies.
Key words:
Neoplasm, kidney; Neoplasm, bladder; Neoplasm, prostate; Disease burden
Contributor Information
Wang Le
Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China
Li Huizhang
Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China
Zhu Juan
Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China
Wang Zongping
Department of Urology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China
Du Lingbin
Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China